Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) is anticipated to release its earnings data before the market opens on ...

Intech Investment Management LLC raised its holdings in shares of Atossa Therapeutics, Inc. (NASDAQ:ATOS – Free Report) by ...

Just because a business does not make any money, does not mean that the stock will go down. For example, although Amazon.com made losses for many years after listing, if you had bought and held the ...

Good morning, everyone, and welcome to the Atossa Therapeutics Fourth Quarter and Full Year 2024 Earnings Conference Call. My name is Joelle, and I will be your conference operator today.

All listeners should provide the operator with the conference call name "Atossa Therapeutics Business Update" to join. Following the conclusion of the conference call, a replay will be available ...

Atossa Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.06. Operator: Good morning, everyone, and welcome to the Atossa Therapeutics Fourth Quarter and ...

SEATTLE, March 25, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company ...

Atossa Therapeutics, Inc. (($ATOS)) has held its Q4 earnings call. Read on for the main highlights of the call. Atossa Therapeutics’ recent ...